Immediate Impact
54 standout
Citing Papers
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
2024 Standout
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
2024 Standout
Works of Jau‐Chen Lin being referenced
TROP2 is epigenetically inactivated and modulates IGF‐1R signalling in lung adenocarcinoma
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jau‐Chen Lin | 128 | 77 | 48 | 105 | 17 | 321 | |
| Xin Wang | 144 | 73 | 24 | 84 | 29 | 321 | |
| Shaoshui Chen | 166 | 69 | 38 | 96 | 16 | 322 | |
| R. L. Carter | 127 | 81 | 49 | 56 | 17 | 313 | |
| Wei Zhang | 118 | 53 | 62 | 157 | 21 | 336 | |
| Jasmina Obradović | 136 | 114 | 20 | 108 | 14 | 327 | |
| Syed F. Zafar | 130 | 50 | 21 | 109 | 18 | 344 | |
| Ziping Sun | 116 | 75 | 27 | 64 | 23 | 302 | |
| Jessica Cades | 251 | 83 | 48 | 124 | 11 | 353 | |
| He Hu | 161 | 54 | 53 | 129 | 17 | 327 | |
| Xiaowei Dong | 153 | 109 | 15 | 114 | 22 | 333 |
All Works
Login with ORCID to disown or claim papers
Loading papers...